/
Imp Instructions to the scholars Imp Instructions to the scholars

Imp Instructions to the scholars - PowerPoint Presentation

WheresMyPizza
WheresMyPizza . @WheresMyPizza
Follow
345 views
Uploaded On 2022-07-28

Imp Instructions to the scholars - PPT Presentation

Use the template Given in the following slides ie Slide no 2 to 9 to prepare your presentation Max no of slides in a presentation is 8 to 9 including Title amp Thank you slides Delete this instruction Slide before submitting ID: 929987

group rats study wistar rats group wistar study drug animal receive dose trial animals answer amp test days suggestive

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Imp Instructions to the scholars" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Imp Instructions to the scholars

Use the template Given in the following slides i.e. Slide no. 2 to 9 to prepare your presentation. Max no. of slides in a presentation is 8 to 9 including Title & Thank you slides.Delete this instruction Slide before submitting.Save the final presentation either as .pptx or .pdf file.Name of the file should be like – yourname_dept.name. Send this file to dddu@nia.edu.in positively before 22nd August 2021.Should you have any doubts and queries, contact I/C DDDU.Come prepared about your study.

1

Slide2

Presentation for IAEC Approval on

“TITLE OF THE STUDY AS MENTIONED IN SYNOPSIS” Principle InvestigatorNAME OF THE SCHOLAR MD / PHD Scholar, Department of ………..,N.I.A. Submitted & Presented to

IAEC

Drug Discovery and Development Unit,

NATIONAL INSTITUTE OF AYURVEDA

Deemed To be University (De Novo)

Ministry of AYUSH, Govt. of India

2

Slide3

Introduction

Introduction about Project Drug and Experimental Model in 4-5 Lines3

Slide4

OBJECTIVES, HYPOTHESES

Mention objectives, hypotheses and justification of the study.4-5 lines.4

Slide5

ANIMALS REQUIRED

(Mention the no. of animals reqd. in the following format)

STUDY & GROUPS

SPECIES & STRAIN

AGE & WEIGHT

GENDER

F / M

NUMBER OF ANIMALS

For example-

Toxicity Study, 1 gr.

Albino Wistar Rats

12-24 weeks,

125-150

gms

3 M, 3 F

06 x1 = 06

For ex – Antidiabetic study, 4 groupsAlbino Wistar Rats12-24 weeks,125-150 gmsF/M06x4 = 24

5

Slide6

Rationale for animal usage

(Answer the following 4 questions)Q. Why is animal usage necessary for these studies?Suggestive Answer – Due to the anatomical similarity in between selected species and human. Unavailability of in vitro experimental model. Our plant sample requires to establish safety and Efficacy. Q. Whether similar study has been conducted on in vitro

models? If yes, describe the leading points to justify the requirement of animal experiment.

Suggestive Answer –

No.

 

Q. Why are the particular species selected?Suggestive Answer –

Wistar Rats are most common experiment animal species having the best reproducibility of results and reliable models for pharmacological activity evaluation of natural products. 

Q. Why is the estimated number of animals essential?

Suggestive Answer –

According to OECD guideline 423 3 animal is necessary in each group for conduct an oral acute toxicity study a

nd six animal is necessary in each group for validation and compete statically analysis. That’s why we required 30 rats.

6

Slide7

Plan of Experimental Study

Use 1 or 2 slides if reqd(Give the following details – examples below)A. Oral Acute Toxicity Study: Oral Acute toxicity of Trial drug Name will be conducted according to OECD guideline 423.Study Design: Three animals will be selected for each group. The dose level will be used as follows:Group 1 : Three Wistar rats will receive

Trial drug Name

. 3000/kg/PO.

Group 2 : Three Wistar rats will receive

Trial drug Name

. 2000 mg/kg/ PO.Administration of Doses: The test formulation will be administered in a single dose by gavages using oral feeding needles. Animal will kept fasting prior to dosing. Following the period of fasting, the weight of each animal will be measured and the test formulation will be administered.

Observation:

Single dose will be administered and Behavior, Hematological and

Histo

-pathological evaluation will be done according to OECD Guideline.

B.

Paracetamol

induced

Hepatotoxicity

.

Twenty four Wistar Rats will receive drug 1000mg/kg Paracetamol orally for seven days for inducing of Hepatotoxicity. Twenty four wistar Rats will be divided into four groups. Each groups contains six rats.Group I (Negative Control): Six Wistar Rats will receive Distilled Water(DW) 5ml/kg/PO for 30 days.Group II (Standard Control): Six Wistar Rats will receive Standard drug/dose in mg/kg/PO for 30 days.Group III (Test Group I): Six Wistar Rats will receive Trial drug one/dose in mg/kg/PO for 30 days.

Group IV (Test Group II):

Six Wistar Rats will receive Trial drug 2 / dose in mg/kg/PO for 30 days.

Evaluation Parameters:-

Liver Function Test

Histopathology of Liver 

7

Slide8

Other Details

Invasive/stressful/ non-invasive procedures : Write the applicable one.Injectable Intervention (Doses, Site, Volume): Yes or no.Blood withdrawal Details: Yes/ No. Volumes: Sites:Radiation (dosage and schedules): NANature of compound/Broad Classification of drug/NCE:

Herbal / Synthetic

Does the protocol prohibit use of anesthetic or analgesic for the conduct of

painful procedures?-

Yes/ No.Will survival surgery be done?-

Yes /NoDescribe method of Euthanasia (If required in the protocol): High dose of anesthetic (Halothane)

Method of carcass disposal after euthanasia:

Biomedical waste disposal

8

Slide9

Thank You

9